|
|
What: Luncheon with the Experts presented by the Carcinoid Cancer Foundation
Who: Jerome S. Zacks, MD, is the featured guest
When: Thursday, August 26, 2021 from 12 noon to 1 pm, Eastern Time
Where: CCF’s Facebook Page, https://www.facebook.com/Carcinoid/. Just come to the page at noon and the program will begin. There is no need to register nor is there a special link.
For anyone not on Facebook, each of the presentations in the series is available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK LIKE, SUBSCRIBE and HIT THE BELL to receive notifications each time a new video is uploaded.
| |
Jerome S. Zacks, MD, cardiologist, has extensive experience caring for patients with carcinoid heart disease. He is the founder of the Carcinoid Heart Center, located in New York City. The Center’s patient focus is two-fold: first, on issues related to carcinoid syndrome and its resultant carcinoid heart disease. Second, based on the belief that a healthy heart is important when living with neuroendocrine cancer and all its manifestations and complications, the Carcinoid Heart Center focuses on all the important cardiovascular risk factors, including hypertension, diabetes, lipid disorders, obesity, smoking behavior, homocysteine, cardio-selective C-reactive protein, dietary factors and life-style/exercise habits. Dr. Zacks is also Associate Clinical Professor of Medicine, Cardiology, at the Icahn School of Medicine at Mount Sinai in New York City.
Dr. Zacks is a co-author of “Diagnosing and Managing Carcinoid Heart Disease in Patients with Neuroendocrine Tumors: An Expert Statement,” published in the Journal of the American College of Cardiology. Given that up to 50 percent of neuroendocrine cancer (carcinoid) patients go on to develop carcinoid heart disease, which is often more life-threatening for patients than the usually slow-growing neuroendocrine tumors, these guidelines are a huge step towards the goal of educating patients and doctors about the current gold standard in diagnosis and treatment.
| |
|
|
|
|
|
|
|
